Role of definitive radiation therapy for larynx preservation in patients with advanced laryngeal cancer

Journal of Otolaryngology

Volumn 28, Issue 5, 1999, Pages 245-251

  Keum, Ki Chang ^a   Kim, Gwi Eon ^a   Suh, Chang Ok ^a   Lee, Jong Young ^a   Roh, Jae Kyung ^a   Kim, Kwang Moon ^b   Kim, Young Ho ^b   Hong, Won Pyo ^b  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Larynx preservation; Neoadjuvant chemotherapy; Radiation therapy

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; FEMALE; HEAD AND NECK CANCER; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LARYNX CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TREATMENT FAILURE;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; CHI-SQUARE DISTRIBUTION; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0344339714     PISSN: 03816605     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Fletcher GH, Goepfert H. Larynx and pyriform sinus. In: Fletcher GH, ed. Textbook of radiotherapy. 3rd Ed. Philadelphia: Lea & Febiger, 1980:330-363.
2. Goepfert H, Jess RH, Fletcher GH, et al. Optimal treatment for the technically resectable squamous cell carcinomas of the supraglottic larynx. Laryngoscope 1975; 85:14-32.
3. Harris HS Jr, Watson FR, Spratt JS Jr. Carcinoma of the larynx: a retrospective study of 144 cases. Am J Surg 1969; 118: 674-684.
4. Harwood AR, Bryce DP, Rider WD. Management of T3 glottic cancer. Arch Otolaryngol 1980; 106:697-699.
5. DeSanto LW. T3 glottic cancer: options and consequences of the options. Laryngoscope 1984; 94:1311-1315.
6. Kazem I, van den Broek P. Planned preoperative radiation therapy vs definitive radiotherapy for advanced laryngeal carcinoma. Laryngoscope 1984; 94:1355-1358.
7. Harwood AR, ENT Group. The management of advanced supraglottic carcinoma by delayed combined therapy [abstract]. Int J Radiat Oncol Biol Phys 1982; 8(Suppl): 101-102.
8. Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 1991; 324:1685-1690.
9. Pfister D, Strong E, Harrison L, et al. Larynx preservation with combined chemotherapy and radiation therapy in advanced but resectable head and neck cancer. J Clin Oncol 1991; 9:850-859.
10. Karp D, Carter R, Vaughan C, et al. Larynx preservation with induction chemotherapy and radiation as alternative to laryngectomy. Am J Clin Oncol 1991; 14:273-279.
11. Demard F, Chauvel P, Sandtini J, et al. Response to chemotherapy as justification for modification of the therapeutic strategy for pharyngolaryngeal carcinomas. Head Neck 1990; 12:225-231.
12. Jacobs C, Goffinet DR, Goffinet L, et al. Chemotherapy as a substitute for surgery in the treatment of advanced resectable head and neck cancer. Cancer 1987; 60:1178-1183.
13. Harwood AR, Beale FA, Cummings BJ, et al. Supraglottic laryngeal carcinoma: an analysis of dose-time-volume factors in 410 patients. Int J Radiat Oncol Biol Phys 1983; 9: 311-319.
14. Croll GA, Gerritsen GJ, Tiwari RM, et al. Primary radio-therapy with surgery in reserve for advanced laryngeal carcinoma: results and complications. Eur J Surg Oncol 1989; 15:350-356.
15. Adjuvant chemotherapy for advanced head and neck squamous carcinoma: final report of the Head and Neck Contracts Program. Cancer 1987; 60:301-311.
16. Schuller DE, Metch B, Stein DW, et al. Preoperative chemotherapy in advanced resectable head and neck cancer: final report of the Southwest Oncology Group. Laryngoscope 1988; 98:1205-1211.
17. Taylor SG IV, Applebaum E, Showel JL, et al. A randomized trial of adjuvant chemotherapy in head and neck cancer. J Clin Oncol 1985; 3:672-679.
18. Stell PM, Dalby JE, Strickland P, et al. Sequential chemotherapy and radiotherapy in advanced head and neck cancer. Clin Radiol 1983; 34:463-467.
19. Hong WK, O'Donogue GM, Sheetz S, et al. Sequential response patterns to chemotherapy and radiotherapy in head and neck cancer: potential impact to treatment in advanced laryngeal cancer. Prog Clin Oncol Res 1985; 201: 191-197.
20. Ensley JF, Jacobs JR, Weaver A, et al. Correlation between response to cisplatinum-combination chemotherapy and subsequent radiotherapy in previously untreated patients with advanced squamous cell cancers of the head and neck. Cancer 1984; 54:811-814.
21. Jacobs C, Makuch R. Efficacy of adjuvant chemotherapy for patients with resectable head and neck cancer: a subset analysis of the Head and Neck Contracts Program. J Clin Oncol 1990; 8:838-847.
22. Schuller DE, Stein DW, Metch B. Analysis of treatment failure patterns. A Southwest Oncology Group study. Arch Otolaryngol Head Neck Surg 1989; 115:834-836.
23. Tannock IF, Cummings BJ. Neoadjuvant chemotherapy in head and neck cancer: no way to preserve a larynx. J Clin Oncol 1992; 10:343-344.
24. Clark JR, Fallon B. Chemotherapeutic strategy in multidisciplinary treatment of head and neck cancer. Semin Oncol 1988; 15(Suppl):35-44.